Manufacturing, Packaging & Detailing Market Research Reports & Industry Analysis
Current Good Manufacturing Practices (cGMPs) refers to the regulations enforced by the FDA. The cGMPs provide for systems that assure proper design, monitoring, and control of manufacturing processes and facilities.
Adherence to the cGMP regulations assures the identity, strength, quality, and purity of drug products by requiring that manufacturers of medications adequately control manufacturing operations. This includes establishing strong quality management systems, obtaining appropriate quality raw materials, establishing robust operating procedures, detecting and investigating product quality deviations, and maintaining reliable testing laboratories. This formal system of controls at a pharmaceutical company, if adequately put into practice, helps to prevent instances of contamination, mix-ups, deviations, failures, and errors. This assures that drug products meet their quality standards.
The cGMP requirements were established to be flexible in order to allow each manufacturer to decide individually how to best implement the necessary controls by using scientifically sound design, processing methods, and testing procedures. The flexibility in these regulations allows companies to use modern technologies and innovative approaches to achieve higher quality through continual improvement.
- Use of RFID in serialized unique packaging numbering to authenticate and check for recall/expiry status.
- Use of X-ray and metal detection systems to detect glass, stone, bone, rubber and other contaminants
- Use of checkweighers and sorters
- Use of baggers capable of handling, opening and sealing bags manufactured from specialist sterile films and papers.
- Use of quality control labeling systems
It is important to note that cGMPs are minimum requirements. Many pharmaceutical manufacturers are already implementing comprehensive, modern quality systems and risk management approaches that exceed these minimum standards. This is important because a consumer cannot detect through smell, touch, or sight if a drug product is safe or if it will work.
Manufacturing, Packaging & Detailing Industry Research & Market Reports
-
Full Container Shrink Sleeves Market – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032
... period. Market growth is primarily driven by the rising demand for visually appealing, cost-efficient packaging solutions across key industries, including food & beverages, personal care, and pharmaceuticals. The increasing preference for shrink sleeves, owing to ... Read More
-
Global Pharmaceutical Warehousing Market 2025-2029
... provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest ... Read More
-
Pharmaceutical Excipients Market, By Product Type (Inorganic Chemicals, Organic Chemicals, Other Products), By Functionality (Fillers and Diluents, Binders, Suspension, Viscosity Agents, Coatings, Flavoring Agents, Disintegrants, Colorants, Preservatives, Others), By Formulation (Oral, Parenteral, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... common excipients include binders, coatings, disintegrants, flavoring agents, lubricants, preservatives, and sweeteners. Global pharmaceutical excipients market growth is driven by factors such as rising generic drug production, growth in oral solid dosage forms, and increasing ... Read More
-
Pharmaceuticals in Mexico: ISIC 2423
... level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - ... Read More
-
Global Astaxanthin Market – Sources, Technologies and Applications
... various health conditions, including inflammation, diabetes, cardiovascular issues, vision problems, and central nervous system disorders. Widely utilized across industries, astaxanthin is used in aquaculture to enhance the pigmentation of salmon, trout, and shrimp; in nutraceuticals ... Read More
-
Hormone Replacement Therapy Market Report by Product (Estrogen Replacement Therapy, Human Growth Hormone Replacement Therapy, Thyroid Replacement Therapy, Testosterone Replacement Therapy, and Others), Route of Administration (Oral, Parenteral, Transdermal), Type of Disease (Menopause, Hypothyroidism, Male Hypogonadism, Growth Hormone Deficiency, and Others), and Region 2025-2033
... 2025-2033. The rising prevalence of hormonal disorders, increased awareness and acceptance of HRT, expanding geriatric population, significant technological advancements and ongoing innovations in delivery methods, supportive government initiatives and reimbursement policies are some of the ... Read More
-
Amaranth Seed Oil Market Size, Share, and Outlook, 2025 Report- By Extraction (Cold Pressed, Organic Solvent, Super Critical CO2 Extraction, Others), By Application (Cosmetics, Food Supplements, Pharmaceutical, Fragrance/Aromatics, Others), 2018-2032
... robust Amaranth Seed Oil Market growth presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Amaranth Seed Oil Market segments across ... Read More
-
Pharmaceutical Contract Packaging Market Report by Industry (Small Molecule, Biopharmaceutical, Vaccine), Type (Sterile, Non-sterile), Packaging (Plastic Bottles, Caps and Closures, Blister Packs, Prefilled Syringes, Parenteral Vials and Ampoules, and Others), and Region 2025-2033
... 2025-2033. The increasing outsourcing trends, rising demand for medications and medical devices, stringent regulatory compliance, product diversification and cost-effectiveness, significant technological advancements, and increasing environmental considerations are some of the major factors propelling the market. ... Read More
-
Guar Gum Powder Market Report by Grade (Food-Grade, Industrial-Grade, Pharmaceutical-Grade), Function (Thickening, Gelling, Binding, Friction Reducing, and Other Functions), End Use Industry (Oil Drilling, Food Industry, Paper and Textile, Pharmaceuticals, Cosmetics, and Others), and Region 2025-2033
... 2025-2033. The rising prevalence of convenience and ready-to-eat (RTE) food items, increasing adoption in pharmaceuticals, and the growing usage of industrial-grade product variants represent some of the key factors driving the market. Guar gum powder ... Read More
-
Brand Name Pharmaceutical Manufacturing in the US - Industry Market Research Report
... Given increasing price scrutiny, competition from generics, intensifying market competition among brand-name producers and rising research and development expenses, many manufacturers have shifted their strategic focus to more lucrative therapy areas, such as rare diseases ... Read More
-
Contract Research Organization Services (CROs)
... Billion by 2030, growing at a CAGR of 10.6% over the analysis period 2024-2030. Clinical Research Services, one of the segments analyzed in the report, is expected to record a 11.4% CAGR and reach US$76.7 ... Read More
-
Analgesics
... 5.3% over the analysis period 2024-2030. Prescription Analgesics, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$43.8 Billion by the end of the analysis period. Growth ... Read More
-
Pharmaceutical Packaging
... CAGR of 8.2% over the analysis period 2024-2030. Plastics & Polymers Material, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$114.0 Billion by the end of ... Read More
-
Chemotherapy-induced Nausea and Vomiting Drugs
... Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Serotonin Receptor Antagonist, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$2.0 ... Read More
-
Fill Finish Manufacturing
... at a CAGR of 8.6% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach US$13.7 Billion by the end of the ... Read More
-
Bulk Paclitaxel
... CAGR of 8.5% over the analysis period 2024-2030. Semi-Synthetic Paclitaxel API, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$139.1 Million by the end of the ... Read More
-
Pharmaceutical Excipients
... CAGR of 4.5% over the analysis period 2024-2030. Organic Chemicals, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$9.8 Billion by the end of the analysis ... Read More
-
Pharmaceutical Contract Packaging
... at a CAGR of 5.8% over the analysis period 2024-2030. Primary Packaging, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$25.7 Billion by the end of ... Read More
-
Pharmacy Automation
... CAGR of 6.9% over the analysis period 2024-2030. Medication Dispensing Systems, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$3.3 Billion by the end of the ... Read More
-
Sterile Medical Packaging
... at a CAGR of 7.3% over the analysis period 2024-2030. Plastics Material, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$36.5 Billion by the end of ... Read More
-
Isosorbide
... 7.4% over the analysis period 2024-2030. PEIT Application, one of the segments analyzed in the report, is expected to record a 9.1% CAGR and reach US$439.5 Million by the end of the analysis period. Growth ... Read More
-
Antibacterial Drugs
... CAGR of 3.8% over the analysis period 2024-2030. ß-lactams, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$35.4 Billion by the end of the analysis period. ... Read More
-
Coenzyme Q10
... CAGR of 4.5% over the analysis period 2024-2030. Dietary Supplements Application, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$609.1 Million by the end of the ... Read More
-
ePedigree Software
... CAGR of 17.3% over the analysis period 2024-2030. On-Premise Deployment, one of the segments analyzed in the report, is expected to record a 16.5% CAGR and reach US$4.6 Billion by the end of the analysis ... Read More
-
Middle East & Africa Halal Pharmaceuticals Market Forecast 2025-2032
... and the forecasting years are from 2025 to 2032. MARKET INSIGHTS The halal pharmaceuticals market in the Middle East & Africa has experienced significant growth due to a combination of rising consumer demand and regulatory ... Read More